FDA inspection
Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.: FDA inspection ending Sep 12, 2025
FDA inspection 1291762 · Voluntary Action Indicated (VAI) · Changzhou
Key facts
| Inspection ID | 1291762 |
|---|---|
| Firm | Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd. |
| FEI number | 3001599766 |
| Address | Huzhuangtou, No. 302 Sanhuangmiaocun; Zhengluzhen Wujin Districtzhenglu, Tianning |
| City | Changzhou |
| Country | China |
| Fiscal year | 2025 |
| Inspection end date | Sep 12, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data